Shi-Yuan Meng

Title: Innovations and Contributions of Inventor Shi-Yuan Meng

Introduction

Shi-Yuan Meng is a notable inventor based in Agoura Hills, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies and polypeptide secretion methods. With a total of 3 patents, her work has the potential to impact various health conditions.

Latest Patents

One of her latest patents involves cannabinoid receptor-1 (CB1) monoclonal antibodies. This disclosure relates to CB1 receptor antigen-binding proteins, such as antibodies and methods of using these antibodies. The CB1 receptor antibodies may comprise an antagonistic antibody to CB1 receptors and can be utilized to treat various health conditions, including obesity and diabetes, or any disease that benefits from antagonism of the CB1 receptor. Another significant patent focuses on enhanced secretion of polypeptides. This patent provides a signal peptide sequence and nucleic acids encoding this sequence, which are useful for improving the secretion efficiency of NGF polypeptides. Additionally, it includes a method for preparing Met-less NGF polypeptides.

Career Highlights

Throughout her career, Shi-Yuan Meng has worked with prominent companies, including Amgen Inc. Her innovative approaches and research have contributed to advancements in therapeutic applications.

Collaborations

Shi-Yuan has collaborated with notable individuals in her field, including Charles Frederick Morris and Larry B. Tsai. These collaborations have further enriched her research and development efforts.

Conclusion

Shi-Yuan Meng's contributions to biotechnology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in health-related technologies.